GROUP EXECUTIVE COMMITTEE

Stephen Saad (57)

Classification: Group Chief Executive

Qualifications: CA(SA), PhD (Commerce) Honoris Causa

Appointed: January 1999

Stephen is a founding shareholder of Aspen. His responsibilities include the strategic positioning of Aspen as a leading multinational pharmaceutical company, global transactions, geographic expansion and product diversification of Aspen in emerging and developed markets.

Sean Capazorio (56)

Classification: Group Chief Financial Officer

Qualifications: CA(SA)

Appointed: January 1999

Sean is responsible for all of the Group’s finance functions across Aspen’s 60 businesses. He also assesses business performance and identifies business improvement opportunities.

Gus Attridge (60)

Classification: Group Chief Advisor

Qualifications: CA(SA)

Appointed: January 1999

Gus is a founding shareholder of Aspen and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit Aspen and our stakeholders.

Richelle Crots (58)

Classification: Regional Chief Executive Officer, SA Commercial

Qualifications: BCom (Human Resources)

Appointed: August 2017

Richelle is responsible for the overall operations of Aspen’s South African Commercial Pharmaceutical business, including SADC countries. She provides executive leadership across this organisation, including overall strategic direction, and leads new business development and opportunities.

Reginald Haman (47)

Classification: Group Chief Corporate Services Officer

Qualifications: MBA, PGDBA, Graduate Diploma in Company Direction

Appointed: May 2020

Reginald is responsible for managing Aspen’s cluster of Group Corporate Services functions. He also ensures the provision of efficient and effective services to the Group in accordance with business and legislative requirements. Reginald was appointed as a member of the Social & Ethics Committee on 1 September 2020.

Lorraine Hill (58)

Classification: Group Chief Operations Officer and Responsible Pharmacist

Qualifications: BPharm

Appointed: January 1999

Lorraine is responsible for multiple operational areas of the business, including strategic manufacturing, pharmaceutical affairs, new product development and strategic procurement. In addition, she plays an integral role in negotiation and implementation of new business initiatives for the Manufacturing business, which she also represents in global transactions.

Samer Kassem (46)

Classification: Chief Executive Officer, Aspen Global Incorporated

Qualifications: CMA, CFM, CBM, MBA

Appointed: May 2008

Samer joined the Group with the responsibility of establishing the company to lead and direct its international operations. He has been integrally involved in the negotiation, completion and integration of strategic acquisitions, the setting up of the Group’s global businesses as well as the trading and supply structures to support these.

Zizipho Mmango (36)

Classification: Group Chief Strategic Development Officer

Qualifications: CA(SA), CFA

Appointed: May 2020

Zizipho is responsible for focusing on assessing and implementing strategic development activities for the Group such as acquisitions, disposals and collaborations. She also plays an active role in advancing business performance and value enhancement opportunities.

Stavros Nicolaou (56)

Classification: Senior Executive Strategic Trade

Qualifications: B.Pharm, FPS (SA), PhD (Medicine) Honoris Causa

Appointed: January 1999

Stavros plays a pivotal role in the initiation of business development opportunities and is also key to the building and maintenance of strategic relations within industry and with all of Aspen’s stakeholders.

Mark Sardi (52)

Classification: Group Chief Commercial Officer

Qualifications: CA(SA)

Appointed: January 2022

Mark is responsible for the direction of all commercial activities in selected international territories including Europe, Russia CIS, Brazil, Latin America, Canada, Middle East, North and sub Saharan Africa and providing strategic leadership in developing Aspen’s commercial operations in these territories while ensuring alignment with the Group’s business strategy.

Trevor Ziman (50)

Classification: Regional Chief Executive Officer, Asia Pacific

Qualifications: CA(SA)

Appointed: May 2001

Trevor is responsible for the implementation of strategy and the performance delivery of Aspen’s Commercial Pharmaceutical businesses in Australasia, the Philippines, Taiwan, Malaysia and Hong Kong as well as trade into the rest of the Asia Pacific region. He plays a leading role in all transactional activity in the region.